000 | 01945 a2200565 4500 | ||
---|---|---|---|
005 | 20250514074603.0 | ||
264 | 0 | _c20030923 | |
008 | 200309s 0 0 eng d | ||
022 | _a0735-7907 | ||
024 | 7 |
_a10.1081/cnv-120018224 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorse, Michael A | |
245 | 0 | 0 |
_aImmunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. _h[electronic resource] |
260 |
_bCancer investigation _cJun 2003 |
||
300 |
_a341-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCarcinoembryonic Antigen _xadverse effects |
650 | 0 | 4 |
_aColonic Neoplasms _xpathology |
650 | 0 | 4 |
_aDendritic Cells _xphysiology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aLeukapheresis |
650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aTransfection _xmethods |
650 | 0 | 4 |
_aTransplantation, Autologous _xadverse effects |
700 | 1 | _aNair, Smita K | |
700 | 1 | _aMosca, Paul J | |
700 | 1 | _aHobeika, Amy C | |
700 | 1 | _aClay, Timothy M | |
700 | 1 | _aDeng, Yuping | |
700 | 1 | _aBoczkowski, David | |
700 | 1 | _aProia, Alan | |
700 | 1 | _aNeidzwiecki, Donna | |
700 | 1 | _aClavien, Pierre-A | |
700 | 1 | _aHurwitz, Herbert I | |
700 | 1 | _aSchlom, Jeffrey | |
700 | 1 | _aGilboa, Eli | |
700 | 1 | _aLyerly, H Kim | |
773 | 0 |
_tCancer investigation _gvol. 21 _gno. 3 _gp. 341-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1081/cnv-120018224 _zAvailable from publisher's website |
999 |
_c12676367 _d12676367 |